Company news: IMS Health, Havas Drive, Healthline Networks

Share this article:
IMS Health launched the IMS Institite for Healthcare Informatics, a bigthink initiative focusing on the use of medical information globally, the future global role of biopharmas, the role of innovation in health system products, processes and delivery systems, and advancement of healthcare agendas in developing nations.

Family practitioners are consistently the physicians most targeted by industry emails, but specialty physicians are more likely to open and click, a survey by Cegedim's SK&A unit found. In 2010, around 17% of all emails targeted family practitioners, but the highest open rates were for trauma surgeons (13.4%), hepatologists (13.2%) and dermatopathologists (11.1%).

Healthline Networks added several publishing partners to its media network, including Ask.com, DoctorOz.com, DailyStrength, DailyRx, Inspire and the Forward Health group, (Women's Health Base, Men's Health Base, All-Allergines.com and Good Cholesterol Count.com). The San Francisco-based firm claims a potential reach of 43 million unique visitors each month.

Havas Drive launched a unit offering “patient-centric services geared toward persons with disabilities and those undergoing rehabilitative therapies.” The new unit will offer strategic and technological products – including tablets, gaming consoles, haptic interfaces, virtual prosthetics, adaptive therapies, text-to-speech functionality and Second Life – serving populations with low vision, blindness, autism, degermative illnesses, behavioral disorders, cognitive difficulty and the hearing impaired.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs


Reimagining healthcare? We want to hear about it.
 
Submit nominations here for MM&M's first-ever list of the Top 40 Healthcare Transformers

Email Newsletters

MM&M inVISION

More in Business Briefs

Novartis said to be stepping out of HCV

Novartis is said to have relinquished rights to an investigational hep. C treatment, signaling its exit from the therapeutic space, according to a former partner's announcement.

Monday Moves: September 15

Hires and promotions for manufacturers, regulatory and agencies

Kantar acquires Evidências, expands Brazilian presence

The company's acquisition signals the growing importance of understanding the Brazilian healthcare market and evidence-based healthcare management services.